Jason Kimata

Associate Professor

Baylor College of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Associate Professor Jason Kimata is affiliated with Baylor College of Medicine in the United States. His research focuses on the elimination of HIV reservoirs, optimization of cellular transduction methods for viral platforms, and the development of vaccines against various coronaviruses and lentiviruses. Recent publications highlight his work on antiviral strategies and immune responses to viral infections, emphasizing innovative approaches to vaccine development.

Articles (19)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (7)

Lihong Liu

Columbia University Vagelos College of Physicians and Surgeons

UNITED STATES

View details

Cristina Poveda

Assistant Professor

Baylor College of Medicine

UNITED STATES

View details

Jeroen Pollet

Assistant Professor

Baylor College of Medicine

UNITED STATES

View details

Peter L. Anderson

UNITED STATES

View details

Alba Frias-De-Diego

Assistant Professor

Tennessee Tech University

UNITED STATES

View details

Jin Wang

Professor of Immunology in Surgery

Weill Cornell Medical College

UNITED STATES

View details

Elisa Crisci

Assistant Professor

North Carolina State University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jason Kimata

Research Interests

Explore related searches

Contact this professor

About

Articles (19)

Elimination of Human Immunodeficiency Virus Reservoirs Harboring Intact Proviruses

Optimization of Cellular Transduction by the HIV-Based Pseudovirus Platform with Pan-Coronavirus Spike Proteins

A trivalent protein-based pan-Betacoronavirus vaccine elicits cross-neutralizing antibodies against a panel of coronavirus pseudoviruses.

Pro-inflammatory feedback loops define immune responses to pathogenic Lentivirus infection.

Variable antiviral activity of islatravir against M184I/V mutant HIV-1 selected during antiretroviral therapy

Pseudoviruses, a safer toolbox for vaccine development against enveloped viruses.

A rapid, high-throughput, viral infectivity assay using automated brightfield microscopy with machine learning.

Long-acting refillable nanofluidic implant confers protection against SHIV infection in nonhuman primates.

From concept to delivery: a yeast-expressed recombinant protein-based COVID-19 vaccine technology suitable for global access.

Antiviral potency of long-acting islatravir subdermal implant in SHIV-infected macaques.

A Recombinant Protein XBB.1.5 RBD/Alum/CpG Vaccine Elicits High Neutralizing Antibody Titers against Omicron Subvariants of SARS-CoV-2

Engineered CD4 T cells expressing a membrane anchored viral inhibitor restrict HIV-1 through cis and trans mechanisms

HIV-1 subtype F integrase polymorphisms external to the catalytic core domain contribute to severe loss of replication capacity in context of the integrase inhibitor resistance mutation Q148H.

Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern.

Clearance of HIV-1 or SIV reservoirs by promotion of apoptosis and inhibition of autophagy: Targeting intracellular molecules in cure-directed strategies.

Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate

In vivo Serial Passaging of Human–Simian Immunodeficiency Virus Clones Identifies Characteristics for Persistent Viral Replication

Serum IgG anti-SARS-CoV-2 Binding Antibody Level Is Strongly Associated With IgA and Functional Antibody Levels in Adults Infected With SARS-CoV-2

SARS-CoV-2 likely targets cellular PDZ proteins: a common tactic of pathogenic viruses

Collaborators (7)

Lihong Liu

Cristina Poveda

Jeroen Pollet

Peter L. Anderson

Alba Frias-De-Diego

Jin Wang

Elisa Crisci

Make your next move.